DSS · Dss, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.33M | - | $6.39M | $5.29M | $4.95M | - | $5.60M | $4.21M | $3.87M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $4.29M | - | $3.56M | $3.21M | $3.49M | - | $3.67M | $3.47M | $3.56M | - |
| Total Operating Expenses | $9.82M | - | $9.63M | $8.71M | $8.68M | - | $10.27M | $9.15M | $8.55M | - |
| D&A | $633.0K | - | - | - | $523.0K | - | - | - | $582.0K | - |
| Operating Income | ($5.49M) | - | ($3.23M) | ($3.42M) | ($3.73M) | - | ($4.67M) | ($4.93M) | ($4.68M) | - |
| Interest Expense | $39.0K | - | $38.0K | $123.0K | $33.0K | - | $53.0K | $142.0K | $48.0K | - |
| Income Tax | - | - | - | - | ($67.0K) | - | - | ($188.0K) | $25.0K | - |
| Net Income | ($4.78M) | - | ($2.30M) | ($2.15M) | ($4.07M) | - | ($5.28M) | ($4.68M) | ($4.07M) | - |
| EPS - Basic | - | - | - | - | - | - | ($0.75) | ($0.66) | ($0.58) | - |
| EPS - Diluted | - | - | - | - | - | - | ($0.75) | ($0.66) | ($0.58) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.94M | $6.21M | $7.02M | $9.38M | $10.83M | $11.43M | $11.63M | $10.72M | $9.25M | $6.62M |
| Accounts Receivable | $2.04M | $2.25M | $4.14M | $2.69M | $2.63M | $3.07M | $2.65M | $2.53M | $2.86M | $3.99M |
| Inventory | $1.82M | $2.00M | $2.87M | $2.54M | $2.50M | $2.44M | $3.31M | $3.57M | $3.63M | $2.82M |
| Accounts Payable | $3.02M | $2.60M | $3.11M | $2.51M | $2.43M | $2.79M | $3.40M | $3.43M | $4.08M | $3.65M |
| Current Assets | $10.69M | $14.35M | $17.10M | $18.88M | $52.82M | $63.82M | $68.81M | $67.70M | $72.16M | $74.63M |
| Total Assets | $71.27M | $67.63M | $92.12M | $93.39M | $92.44M | $106.45M | $142.66M | $144.45M | $148.50M | $153.19M |
| Current Liabilities | $47.69M | $47.50M | $54.19M | $53.83M | $54.05M | $65.03M | $59.08M | $57.67M | $56.21M | $55.61M |
| Long-term Debt | $5.50M | $5.73M | $5.97M | $6.17M | $2.40M | $2.40M | $7.44M | $7.03M | $7.43M | $7.45M |
| Total Liabilities | $58.72M | $58.91M | $66.02M | $66.02M | $73.74M | - | $69.98M | - | - | - |
| Stockholders' Equity | $3.38M | ($832.0K) | $14.20M | $15.67M | $17.86M | $20.24M | $52.12M | $55.17M | $59.85M | $63.93M |
| Retained Earnings | ($332.82M) | ($327.00M) | ($312.26M) | ($310.00M) | ($307.85M) | ($303.07M) | ($270.21M) | ($264.93M) | ($260.25M) | ($256.18M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($133.0K) | - | - | - | ($1.64M) | - | - | - | ($2.15M) | - |
| Investing Cash Flow | ($2.64M) | - | - | - | $12.88M | - | - | - | $5.10M | - |
| Financing Cash Flow | $1.39M | - | - | - | ($11.69M) | - | - | - | ($310.0K) | - |
| CapEx | - | - | - | - | $52.0K | - | - | - | $3.0K | - |
| Free Cash Flow | - | - | - | - | ($1.69M) | - | - | - | ($2.15M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -126.7% | - | -50.6% | -64.8% | -75.2% | - | -83.4% | -117.2% | -120.9% | - |
| EBITDA margin | -112.1% | - | - | - | -64.7% | - | - | - | -105.9% | - |
| Net margin | -110.3% | - | -36.0% | -40.7% | -82.2% | - | -94.4% | -111.2% | -105.2% | - |
| Free cash flow margin | - | - | - | - | -34.1% | - | - | - | -55.6% | - |
| FCF / Net income | - | - | - | - | 0.42 | - | - | - | 0.53 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 98.9% | - | 55.7% | 60.8% | 70.5% | - | 65.5% | 82.5% | 92.0% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -6.7% | - | -2.5% | -2.3% | -4.4% | - | -3.7% | -3.2% | -2.7% | - |
| Return on equity | -141.5% | - | -16.2% | -13.7% | -22.8% | - | -10.1% | -8.5% | -6.8% | - |
| Return on invested capital | - | - | - | - | -14.5% | - | - | -6.3% | -5.5% | - |
| Liquidity | ||||||||||
| Current ratio | 0.22 | 0.30 | 0.32 | 0.35 | 0.98 | 0.98 | 1.16 | 1.17 | 1.28 | 1.34 |
| Quick ratio | 0.19 | 0.26 | 0.26 | 0.30 | 0.93 | 0.94 | 1.11 | 1.11 | 1.22 | 1.29 |
| Cash ratio | 0.10 | 0.13 | 0.13 | 0.17 | 0.20 | 0.18 | 0.20 | 0.19 | 0.16 | 0.12 |
| Leverage | ||||||||||
| Debt / Equity | 1.63 | -6.88 | 0.42 | 0.39 | 0.13 | 0.12 | 0.14 | 0.13 | 0.12 | 0.12 |
| Debt / Assets | 0.08 | 0.08 | 0.06 | 0.07 | 0.03 | 0.02 | 0.05 | 0.05 | 0.05 | 0.05 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -140.7x | - | -85.1x | -27.8x | -112.9x | - | -88.1x | -34.8x | -97.5x | - |
| Equity multiplier | 21.12 | -81.29 | 6.49 | 5.96 | 5.17 | 5.26 | 2.74 | 2.62 | 2.48 | 2.40 |
| Liabilities / Assets | 0.82 | 0.87 | 0.72 | 0.71 | 0.80 | - | 0.49 | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.06 | - | 0.07 | 0.06 | 0.05 | - | 0.04 | 0.03 | 0.03 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 172d | - | 236d | 186d | 194d | - | 173d | 219d | 270d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 2.4x | - | 0.9x | 0.5x | 0.4x | - | 0.2x | 0.2x | 0.2x | - |
| P / S | 1.8x | - | 1.9x | 1.6x | 1.5x | - | 1.6x | 2.9x | 3.3x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -12.6% | - | 14.2% | 25.5% | 28.0% | - | 33.9% | -41.8% | -67.5% | - |
| Revenue CAGR (3y) | -28.7% | - | -18.6% | -23.4% | -26.2% | - | 7.0% | 0.2% | -7.8% | - |
| Revenue CAGR (5y) | -2.6% | - | 8.9% | 11.1% | -0.2% | - | 9.6% | 0.5% | 54.3% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -47.3% | - | 30.8% | 30.6% | 20.4% | - | 8.5% | 23.5% | 16.1% | - |
| Net income growth (YoY) | -17.3% | - | 56.5% | 54.0% | 0.0% | - | 73.9% | 87.7% | 49.3% | - |
| EPS growth (YoY) | - | - | - | - | - | - | -2400.0% | -144.4% | -866.7% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | 21.5% | - | - | - | 85.4% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -81.1% | - | -72.7% | -71.6% | -70.2% | -68.3% | -44.7% | -44.1% | -49.1% | -49.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$23.36M totalProduct Packaging$18.15M · 77.7%
Securities$2.52M · 10.8%
Securities Revenue Information$2.52M · 10.8%
Commercial Banking$45.0K · 0.2%
Commercial Lending Revenue Information$45.0K · 0.2%
Biotechnology$38.0K · 0.2%
Biotechnology Revenue Information$38.0K · 0.2%
Product / service
$39.83M totalPrinted Products$18.09M · 45.4%
Printed Products Revenue Information$17.71M · 44.5%
Commission$1.35M · 3.4%
Commission Income$1.28M · 3.2%
Rental Income$1.24M · 3.1%
Commercial Lending$45.0K · 0.1%
Net Investment Income$45.0K · 0.1%
Biotechnology$38.0K · 0.1%
Retail Internet Sales$38.0K · 0.1%
Peer comparison
Same SIC group: Paperboard Containers & Boxes
Comparing DSS against the 5 most active filers in the same SIC group.